Navigating Patient Journey in Early Diagnosis of Lung Cancer in India
Overview
Authors
Affiliations
Lung cancer (LC) is one of the leading causes of cancer deaths worldwide. In India, the incidence of LC is increasing rapidly, and a majority of the patients are diagnosed at advanced stages of the disease when treatment is less likely to be effective. Recent therapeutic developments have significantly improved survival outcomes in patients with LC. Prompt specialist referral remains critical for early diagnosis for improved patient survival. In the Indian scenario, distinguishing LC from benign and endemic medical conditions such as tuberculosis can pose a challenge. Hence, awareness regarding the red flags-signs and symptoms that warrant further investigations and referral-is vital. This review is an effort toward encouraging general physicians to maintain a high index of clinical suspicion for those at risk of developing LC and assisting them in refering patients with concerning symptoms to specialists or multidisciplinary teams as early as possible.
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions.
Garg P, Singhal S, Kulkarni P, Horne D, Malhotra J, Salgia R J Clin Med. 2024; 13(14).
PMID: 39064229 PMC: 11278207. DOI: 10.3390/jcm13144189.
Tao W, Wen J, Li W Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 54(6):1288-1293.
PMID: 38162072 PMC: 10752780. DOI: 10.12182/20231160301.